Literature DB >> 11578805

In vitro bioassays for anticancer drug screening: effects of cell concentration and other assay parameters on growth inhibitory activity.

M M Lieberman1, G M Patterson, R E Moore.   

Abstract

In vitro growth inhibition assays were performed using human cancer cell lines at various concentrations with experimental anticancer drugs such as the cryptophycins and other cytotoxins. The effect of variations in assay parameters on the observed growth inhibition of these anticancer therapeutic agents was determined. The results demonstrated that the observed inhibitory activity of these compounds varied inversely with the cell concentrations used. The observed differences in activity between different cytotoxins were not necessarily proportionate. Thus, the relative activities of two toxins also varied with cell concentration. Furthermore, the sensitivity of these cell lines to the cytostatic purine analog, 6-mercaptopurine (used as a control), varied with cell concentration as well. The activity of this compound was dependent on the medium used for cell growth, yielding good activity in Eagle's minimum essential medium, but not in Ham's F-12 (Kaigin) medium. Moreover, growth inhibition by cryptophycin as well as 6-mercaptopurine was also dependent on the serum concentration in the medium. Finally, the sensitivity of the cancer cell lines to various organic solvents commonly used as drug vehicles for in vitro testing, such as ethanol, dimethylformamide, and dimethylsulfoxide, was likewise found to vary inversely with cell concentration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578805     DOI: 10.1016/s0304-3835(01)00681-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

Review 1.  Emerging applications of metabolomics in studying chemopreventive phytochemicals.

Authors:  Lei Wang; Chi Chen
Journal:  AAPS J       Date:  2013-06-22       Impact factor: 4.009

2.  Antiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferation.

Authors:  Jiangping Hou; Yuli Li; Zhonglou Zhou; Nadejda Valiaeva; James R Beadle; Karl Hostetler; William R Freeman; Dan-Ning Hu; Hao Chen; Lingyun Cheng
Journal:  Mol Vis       Date:  2011-03-02       Impact factor: 2.367

3.  Comparison of cell-based assays to quantify treatment effects of anticancer drugs identifies a new application for Bodipy-L-cystine to measure apoptosis.

Authors:  Nita Kumar; Rayhaneh Afjei; Tarik F Massoud; Ramasamy Paulmurugan
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

4.  Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs.

Authors:  Dania Movia; Despina Bazou; Yuri Volkov; Adriele Prina-Mello
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

5.  Leucine-rich repeat-containing G protein-coupled receptor 5 marks different cancer stem cell compartments in human Caco-2 and LoVo colon cancer lines.

Authors:  Samah Abdulaali Alharbi; Dmitry A Ovchinnikov; Ernst Wolvetang
Journal:  World J Gastroenterol       Date:  2021-04-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.